Recent research has revealed that individuals carrying a polymorphism in the NECTIN2 gene exhibit a decreased susceptibility to AD when compared to non-carriers, when receiving vaccinations for pneumonia and flu [22]. This evidence concerns the gene NECTIN2 and pneumonia.